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Abstract Naturally occurring oplopanane sesquiterpenoids are rarely reported. A phytochemical investigation on the
rhizomes of Homalomena occulta (Lours) has resulted in the discovery of six oplopanane sesquiterpenoids (1–6), including
four new (1–4) and one 3,5-seco-oplopanane (6), together with three previously reported sesquiterpenoids (7-9). In
addition three new oplopananes (2a–4a) were also obtained by chemical transformation. All structures of these
sesquiterpenoids were established based on the comprehensive spectroscopic analyses, including NMR, MS, and IR, and
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1 Introduction
With its rich cultural heritage and biodiversity, traditional
Chinese medicine (TCM) has potential as a source for the
discovery of structurally novel bioactive compounds.
During the last twenty years, considerable efforts have
been dedicated towards the exploration of the natural
product chemistry of TCM. Homalomena occulta (Lour.)
was officially listed in the Chinese Pharmacopoeia (named
Qian-nian-jian) [1], and was found to occur in the tropical
and sub-tropical areas of Asia and America. The plant has
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been used for the treatment of rheumatoid arthritis,
trengthening tendons and bones, and invigorating the kid-
ney and liver [2, 3]. Recent reports of H. occulta have also
shown that the species is one of the most prolific sources of
compounds with new structures [2–6].
Our research group has considerably focused on phy-
tochemical investigations of TCM [7–10]. As part of our
continuing efforts to obtain novel compounds with exqui-
site structural architectures, we initiated a chemical
investigation of H. occulta, which has thus far led to the
isolation and structural elucidation of six oplopanane
sesquiterpenoids (1–6), including four new (1–4) and one
3,5-seco-oplopanane (6), together with three previously
reported sesquiterpenoids (7-9).
2 Results and Discussion
By means of diverse chromatographic methods, including
silica gel and LH-20, four new oplopanane sesquiter-
penoids (1-4) (Fig. 1) have been purified from an 88 %
ethanol/water extract of the rhizomes of H. occulta.
Compound 1 was isolated as an optically active color-
less oil with ½a20D –54 (c 0.07, CHCl3). Its molecular for-
mula was analyzed as same as oplopanone (5) [11], i.e.
C15H26O2, based on a pseudomolecular ion peak at
m/z 256.2272 [M ? NH4]
? (calcd. 256.2271) in the posi-
tive HRESIMS spectrum, indicating three degrees of
unsaturation. The IR absorptions suggested the existence of
hydroxy (3382 cm-1) and ketone (1705 cm-1) function-
alities. The 13C NMR spectra (Table 1) showed the pres-
ence of one oxygenated quaternary carbon (dC 73.2) and
one ketone carbon (dC 212.3). Overall NMR pattern,
together with the established molecular formula, showed
close resemblance to those of oplopanone (5) [11], which
indicated that compounds 1 and 5 were possibly epimers of
each other. The large coupling constants of JH-1,H-6
(12.0 Hz) and JH-5,H-6 (10.4 Hz) indicated the trans rela-
tionship from H-1 to H-6, and from H-5 to H-6, while the
small coupling constants of JH-6,H-7 (4.0 Hz) suggested H-7
as b-oriented. A molecular modeling study based on no
NOE correlation from H-1 to H3-14 was used to determine
the b-oriented Me-14. Finally, compound 1 was 6-epi-
oplopanone.
Compound 2, obtained as an optically active colorless
oil with ½a20D ?20 (c 0.1, CHCl3), was assigned a molecular
formula C15H26O3 as analyzed from a pseudomolecular ion
at m/z 277.1779 [M ? Na]? (calcd. 277.1774) in its posi-
tive HRESIMS, indicative of three degrees of unsaturation.
Its IR spectrum showed absorptions for hydroxy
(3392 cm-1) and ketone (1704 cm-1) groups. A spectro-
scopic analogy of 2 with 1 indicated that compound 2 was
an oplopanane-type sesquiterpenoid. The significant vari-
ations of 1 and 2 in their 1H NMR spectra were the dis-
appearance of methylene signals of H2-2 (dH 1.90/1.42) in
1 and the appearance of a multiplet at dH 4.10 in 2. These
changes could be explained by the presence of a hydroxy
group at C-2 in compound 2, which was further elucidated
from an HMBC experiment. In confirmation of the relative
configuration, 2 gave a 2-monoacetate (2a) (Table 2) after
overnight treatment with Ac2O/Py (Sect. 3). As in 2a, the
coupling constants J1,6 = 12.4 Hz, J1,2 = 9.2 Hz,
J5,6 = 2.4 Hz, and J6,7 = 8.9 Hz allowed the placement of
H-5, H-6, and H-7 on a-orientation, and H-1 and OH-2 on
a-orientation. The NOE correlations of H3-14 with H-2/H-
6, and H-5 with H-2/H-7 were used to determine H3-14 as
b-oriented. Thus, the structure of 2 was established as 5,7-
diepi-2a-hydroxyoplopanone.
1 5αH, 7βH, R1 = R2 = H, R3 = O
2 5βH, 7βH, R1 = OH, R2 = H, R3 = O
2a 5βH, 7βH, R1 = OAc, R2 = H, R3 = O
3, 4 5αH, 7αH, R1 = R2 = H, R3 = H, OH
3a, 4a 5αH, 7αH, R1 = R2 = H, R3 = H, OAc





























Fig. 1 Molecular structures of sesquiterpenoids 1-9
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Compounds 3 and 4, both isolated as optically active
white floc with ½a20D -17 (c 0.1, CHCl3) and ½a20D -27
(c 0.1, CHCl3), respectively, possessed the same molecular
formula of C15H28O2 based on the positive HRESIMS data
at m/z 258.2422 and 258.2428, respectively ([M ? NH4]
?,
calcd. 258.2428). Their IR peaks at 3398 and 3352 cm-1
suggested the presence of hydroxy groups. Their 13C NMR
spectra were similar to those of 1, with the exception that
the carbonyl carbon at dC 212.3 in 1 was replaced by
hydroxy-bearing methine carbons at dC 68.6 and 69.7 in 3
and 4, respectively. The replacements of the C-4 ketone by
secondary hydroxy group were supported by the presence
of a quartet at dH 3.98 (1H, J = 6.4 Hz, assigned to H-4) of
3 and a doublet of quartet at dH 4.00 (1H, J = 4.0, 6.4 Hz,
assigned to H-4) for 4 in the 1H NMR spectrum, which
were confirmed from HMBC correlations from H-4 to C-3,
Table 1 NMR spectroscopic data for compound 1 in CDCl3
Position dH (J in Hz) dC Position dH (J in Hz) dC
1 2.07, ddd (6.8, 12.0, 12.0) 52.5 (d) 8a
8b
1.55, m
1.01, dd (3.2, 13.6)
23.0 (t)
2a 1.90, m 24.7 (t) 9a 1.77, dt (3.2, 12.4) 42.2 (t)
2b 1.42, m 9b 1.40, m
3a 1.94, dt (2.8, 6.0) 27.5 (t) 10 73.2 (s)
3b 1.58, m
4 212.3 (s) 11 1.67, m 29.2 (d)




6 1.35, ddd (4.0, 10.4, 12.0) 49.1 (d) 14 1.09, s 19.4 (q)
7 1.59, m 42.7 (d) 15 2.15, s 31.5 (q)
Table 2 NMR spectroscopic data for compounds 2, 2a, and 3 in CDCl3
Position 2 2a 3
dH (J in Hz) dC dH (J in Hz) dC dH (J in Hz) dC
1 1.50, m 60.4 (d) 1.75, dd (9.2, 12.4) 59.9 (d) 1.42, dt (4.8, 11.6) 57.5 (d)
2a 4.10, m 72.2 (d) 5.08, ddd (5.6, 8.8, 9.2) 74.0 (d) 1.78, dt (4.8, 12.4) 25.4 (t)
2b 1.18, m
3a 1.82, m 36.9 (t) 2.08, m 35.8 (t) 1.75, m 22.5 (t)
3b 1.82, m 1.93, m 1.58, m
4 210.9 (s) 210.0 (s) 3.98, q (6.4) 68.6 (d)
5 1.75, m 42.2 (d) 2.79, ddd (2.4, 8.0, 10.0) 44.1 (d) 1.72, m 48.9 (d)
6 2.73, m 52.6 (d) 1.86, ddd (2.4, 8.9, 12.4) 53.2 (d) 1.33, m 44.6 (d)
7 1.03, m 49.5 (d) 1.15, m 49.7 (d) 1.18, m 50.1 (d)
8a 1.51, m 22.6 1.58, m 22.3 1.62, m 23.1
8b 1.51, m (t) 1.11, m (t) 1.07, m (t)
9a 1.34, m 41.5 (t) 1.77, m 41.0 (t) 1.73, m 41.8 (t)
9b 1.34, m 1.38, m 1.37, m
10 73.4 (s) 72.0 (s) 73.0 (s)
11 1.30, m 28.7 (d) 1.38, m 29.0 (d) 1.91, m 28.1 (d)
12 and 13 0.61, d (6.8)
0.83, d (6.8)
21.7 (q) 0.66, d (6.8) 21.9 (q) 0.89, d (8.4)
0.93, d (7.2)
15.6 (q)
15.4 (q) 0.89, d (6.8) 15.4 (q) 21.8 (q)
14 1.21, s 20.5 (q) 1.26, s 21.0 (q) 1.17, s 20.1 (q)
15 2.15, s 29.8 (q) 2.20, s 30.1 (q) 1.18, d (6.4) 23.1 (q)
C=O 171.3 (s)
Me 2.04, s 21.3 (q)
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C-5, C-6, and C-15. The structures of 3 and 4 were thus
deduced as epimers of 4,10-dihydroxyoplopanane. The
relative configurations of 3 and 4 were finalized by com-
paring their spectroscopic features with those of 1 and
NOE experiment. The large coupling constants of
J1,6 = 11.6 Hz in 3/4 and 3a/4a (acetate of 3/4, Sect. 3 and
Tables 2, 3) were used to assign H-1 and H-6 as a- and b-
orientation, respectively. Irradiation of H-4 enhanced sig-
nals for H-6 and H-11 in 3a (acetate of 3) and 4 allowed
H-5 and H-7 as a-orientated. Efforts on the determination
of the absolute configurations at C-4 in compounds 3 and 4
by using Mosher method failed. Therefore the structures of
3 and 4 were elucidated as depicted and named oplopa-
nanol and 4-epi-oplopananol, respectively.
On the basis of NMR, MS, optical rotation data and
comparison with literature values, the known sesquiter-
penoids were elucidated as oplopanone (5) [11], taiwani-
none A (6) [12], T-muurolol (7) [13], a-cadinol (8) [14],
and clovane-2b,9a-diol (9) [15]. Naturally occurring
oplopanane sesquiterpenoids are rarely reported [16, 17].
Literature searching showed that there were no more than
20 such type sesquiterpenoids reported up to now, dis-
tributed among the families of Alismataceae [16, 17],
Araliaceae [18], Araceae [19], Asteraceae [20], Chloran-
thaceae [21], Cyperaceae [22], Magnoliaceae [23],
Meliaceae [24], Schisandraceae [25], Salicaceae [26], and
Zingiberaceae [27]. In this study, six oplopananes (1–6),
including four new (1–4) and one 3,5-seco-oplopanane
(6), were discovered from the rhizomes of H. occulta. In
addition three new oplopananes (2a–4a) were also
obtained by chemical transformation. These results indi-




Optical rotations were recorded on a 241 polarimeter
(Perkin-Elmer). Infrared (IR) spectra were obtained with a
FTS 165-IR instrument (Bio-Rad, USA). NMR spectra
were acquired on a Varian INOVA-400 FT-NMR spec-
trometer (USA). HRESIMS were measured on a Bruker
APEX II spectrometer. Sephadex LH-20 (Amersham Bio-
sciences) and silica gel (200–300 mesh, Qingdao Haiyang
Chemical Co., Ltd) were used for column chromatography
(CC), whereas TLC analyses were carried out with glass
plates pre-coated with silica gel and the spots were visu-
alized by spraying with 98 % H2SO4/EtOH in (5/95, v/v)
Table 3 NMR spectroscopic data for compounds 3a, 4, and 4a in CDCl3
Position 3a 4 4a
dH (J in Hz) dC dH (J in Hz) dC dH (J in Hz) dC
1 1.38, m 57.6 (d) 1.44, dt (4.0, 12.8) 57.9 (d) 1.43, dt (4.8, 11.6) 57.7 (d)
2a 1.70, m 25.4 (t) 1.77, m 26.0 (t) 1.74, m 26.0 (t)
2b 1.20, m 1.08, m 1.74, m
3a 1.86, m 24.4 (t) 1.80, m 23.6 (t) 1.80, m 24.2 (t)
3b 1.55, m 1.13, m 1.53, m
4 4.98, q (6.4) 73.1 (d) 4.00, dq (4.0, 6.4) 69.7 (d) 5.06, m 72.7 (d)
5 1.38, m 46.9 (d) 2.05, m 48.7 (d) 2.12, m 45.2 (d)
6 1.14, m 45.1 (d) 0.93, m 46.2 (d) 0.98, m 45.9 (d)
7 1.22, m 50.0 (d) 1.21, m 50.1 (d) 1.18, m 49.9 (d)
8a 1.59, m 23.3 (t) 1.63, ddt (3.2, 4.0, 13.6) 23.4 (t) 1.63, dq (4.0, 13.6) 23.2 (t)
8b 1.03, dt (3.6, 11.6) 1.06, m 1.08, m
9a 1.76, dt (3.6, 12.4) 41.9 (t) 1.76, m 41.9 (t) 1.77, m 41.9 (t)
9b 1.35, m 1.37, dt (4.0, 13.2) 1.36, dt (4.0, 12.8)
10 73.0 (s) 73.0 (s) 73.0 (s)
11 1.86, m 28.2 (d) 1.93, m (2.4) 28.5 (d) 2.09, m 28.1 (d)
12 and 13 0.72, d (7.2)
0.90, d (6.8)
22.0 (q) 0.72, d (6.8)
0.94, d (6.8)
15.7 (q) 0.75, d (6.8)
0.94, d (6.8)
15.7 (q)
15.5 (q) 21.9 (q) 22.0 (q)
14 1.12, s 19.9 (q) 1.14, s 20.1 (q) 1.14, s 20.1 (q)
15 1.19, d (6.4) 19.6 (q) 1.12, d (6.4) 17.0 (q) 1.16, d (6.4) 13.8 (q)
16 170.9 (s) 170.6 (s)
17 2.01, s 21.3 (q) 2.01, s 21.5 (q)
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followed by heating. All solvents used were analytical
grade.
3.2 Plant Materials
The rhizomes of H. occulta Lours (Araceae), collected
from Guangxi in China, were purchased from Lanzhou
Fuxinghou Herbal Medicines Ltd. Co. in February 2007.
The materials were identified by Dr. Huan-Yang Qi at
Lanzhou Institute of Chemical Physics (LICP), and a
voucher specimen (ZY2007H001) was deposited at the
herbarium of LICP.
3.3 Extraction and Isolation
The air-dried rhizomes (13.0 kg) of H. occulta were
powdered and extracted with 88 % ethanol/water (v/v) at
60 C (12 h 9 3). After dried in vacuum, the residue
(410 g) was suspended in water (1.5 L) and applied to a
liquid–liquid partitioning against petroleum ether (PE),
EtOAc, and n-BuOH (each 1.0 L 9 3) continuously. The
dried PE part (257 g) was chromatographed over silica gel
(1.5 kg), using gradient PE/acetone (v/v, from 80:1 to 1:1,
each about 8.0 L) to yield eleven fractions (A1–A11).
Fraction A2 (55 g) was subjected to silica gel CC eluting
with CHCl3/PE gradient system to afford compound 8
(18.2 mg). Fraction A3 (21 g) was purified over silica gel
with PE/CHCl3 (v/v, 1:1) to afford 7 (4.5 mg). Fraction A5
(34 g) was fractionated consecutively over silica gel and
Sephadex LH-20 (CHCl3/MeOH, 1:1, v/v) to yield com-
pound 5 (4.5 mg). Fraction A6 (12 g) was chro-
matographed on a silica gel column eluting with PE/
acetone (v/v, 10:1, 8:1, 5:1, 3:1, and 1:1) to afford com-
pound 1 (5.1 mg). Fraction A7 (15 g) was fractionated
consecutively over silica gel with PE/acetone (8:1) and
Sephadex LH-20 (CHCl3/MeOH, 1:1, v/v) to yield 2
(7.8 mg), 3 (23.1 mg), 4 (17.7 mg), 6 (17.8 mg), and 9
(2.1 mg).
3.3.1 7-Epi-oplopanone (1)
Colorless oil; ½a20D –54 (c 0.07, CHCl3); IR (neat) vmax
3382, 2926, 2857, 1705, 1458, 1383, 1119, 1094,
1027 cm-1; 1H NMR (CDCl3, 400 MHz) and
13C NMR
(CDCl3, 100 MHz) (Table 1); HRESIMS m/z [M ? NH4]
?
256.2272 (calcd for C15H30O2N, 256.2271).
3.3.2 5,7-Diepi-2a-hydroxyoplopanone (2)
Colorless oil; ½a20D ?20 (c 0.1, CHCl3); IR (neat) vmax
3392, 2955, 2935, 2871, 1704, 1460, 1380, 1365, 1173, 1121,
1049 cm-1; 1H NMR (CDCl3, 400 MHz) and
13C NMR
(CDCl3, 100 MHz) (Table 2); HRESIMS m/z [M ? Na]
?
277.1779 (calcd for C15H26O3Na, 277.1774).
3.3.3 Oplopananol (3)
White floc; ½a20D –17 (c 0.1, CHCl3); IR (neat) vmax 3398,
2959, 2933, 1461, 1370, 1129 cm-1; 1H NMR (CDCl3,
400 MHz) and 13C NMR (CDCl3, 100 MHz) (Table 2);
HRESIMS m/z [M ? NH4]
? 258.2422 (calcd for
C15H32O2N, 258.2428).
3.3.4 4-Epi-oplopananol (4)
White floc; ½a20D –27 (c 0.1, CHCl3); IR (neat) vmax 3352,
2956, 2924, 2856, 1571, 1458, 1421, 1365, 1128, 1062,
944 cm-1; 1H NMR (CDCl3, 400 MHz) and
13C NMR
(CDCl3, 100 MHz) (Table 3); HRESIMS m/z [M ? NH4]
?
258.2428 (calcd for C15H32O2N, 258.2428).
3.4 Acetylation of 2 to 4
A solution of compounds in a mixture of acetic anhydride–
pyridine (1:1) were stirred fully and settled at 25 C for
12 h. After concentration and storage in vacuo compounds
2a, 3a, and 4a were obtained and identified.
3.4.1 5,7-Diepi-2a-acetoxyoplopanone (2a)
Colorless oil; ½a20D ?7 (c 0.2, CHCl3); IR (neat) vmax 3449,
2934, 2871, 1734, 1712, 1370, 1247, 1044, 968 cm-1; 1H
NMR (CDCl3, 400 MHz) and
13C NMR (CDCl3,
100 MHz) (Table 2); HRESIMS m/z [M ? Na]? 319.1883
(calcd for C17H28O4Na, 319.1880).
3.4.2 4-Acetoxyoplopananol (3a)
Colorless oil; ½a20D –41 (c 0.2, CHCl3); UV (CHCl3)
kmax(log e) 246 (1.56) nm; IR (neat) vmax 3423, 2960, 2935,
2892, 1736, 1458, 1375, 1247, 1134, 1033, 930 cm-1; 1H
NMR (CDCl3, 400 MHz) and
13C NMR (CDCl3,
100 MHz) (Table 3); HRESIMS m/z [M ? Na]? 305.2091
(calcd for C17H30O3Na, 305.2087).
3.4.3 4-Epi-acetoxyoplopananol (4a)
White floc; ½a20D –10 (c 0.2, CHCl3); UV (CHCl3) kmax(log
e) 246 (1.48) nm; IR (neat) vmax 3420, 2858, 2935, 2872,
1732, 1374, 1248, 1126, 1035, 953 cm-1; 1H NMR
(CDCl3, 400 MHz) and
13C NMR (CDCl3, 100 MHz)
(Table 3); HRESIMS m/z [M ? Na]? 305.2093 (calcd for
C17H30O3Na, 305.2087).
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